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New Ways to Tackle Malaria
Susanta Kumar Ghosh and Chaitali Ghosh
Abstract
Malaria is one of the oldest tropical diseases and still remains a focus of atten-
tion. Sub-Saharan African countries contribute 90% of the total malaria cases in the 
world. The World Health Organization (WHO) has advocated eliminating this dis-
ease by 2030 with the existing strategies and tools. Many initiatives are underway 
by several organizations, and 38 countries have achieved the elimination goal. The 
main backbone of the elimination process is smart surveillance followed by prompt 
public health responses. The control of the disease mainly relies on treatment of 
malaria positive cases with anti-malarials namely artemisinin-based combination 
therapy (ACT) for Plasmodium falciparum. In India, chloroquine is still effective 
against P. vivax. Use of 8-aminoquinolines primaquine and more recently tefeno-
quine warrants testing of G6PD deficiency status to avoid unnecessary hemolysis. 
Vector control operations mainly depend on the use of long-lasting insecticidal nets 
(LLINs) and indoor residual spray (IRS) with insecticides. The threat of resistance 
draws an open challenge in both treatment and vector management. New initiatives 
on surveillance, treatment, chemoprevention, and vector control using modern 
techniques of artificial intelligence, machine learning, genetic engineering, and 
digital approach of community engagement have great potential to accelerate the 
malaria elimination process.
Keywords: malaria, elimination, smart surveillance, treatment, vector management, 
community engagement
1. Introduction
Malaria is one of the oldest parasitic tropical diseases, and it takes a huge toll on 
human lives. It also causes great economic loss. Almost half of the population in the 
world is under the threat of malaria mostly in the tropical and sub-tropical countries. 
About 90% of the total malaria burden occurs in sub-Saharan African countries. Efforts 
to eradicate/or eliminate malaria began after the discovery of the role of mosquitoes 
in malaria transmission by Ronald Ross in 1897. In the beginning of the 20th century, 
most of the mosquito control operations were aimed at larval control using larvicidal 
oil, larvivorous fish and environmental management. These efforts made significant 
impacts on malaria control. Everything changed with the introduction of dichloro 
diphenyl trichloroethane (DDT) in the mid-1940s. Many European countries and the 
USA successfully eradicated malaria with the application of DDT and vector sanitation 
strategies, and improving general living standard [1].
Malaria eradication program in India haves had mixed success. After successful 
results from pilot studies on DDT, the National Malaria Eradication Program (NMEP) 
was launched in 1958 from the National Malaria Control Program (NMCP) in 1953. 
There was a huge success that resulted in almost complete malaria eradication in 
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the mid-1960s with 0.1 million cases and no deaths. A kind of complacency led to a 
slow rise in malaria cases, and a total of 6.4 million cases were reported in 1976. This 
was due to the development of resistance to DDT by vector species, especially by 
Anopheles culicifacies s.l. and chloroquine resistance by P. falciparum malaria [2].
A Modified Plan of Operation (MPO) was launched aiming to treat each fever 
case suspected to be malarial infection with a presumptive dose of anti-malarial 
drug especially chloroquine. This provided some respite but the malaria cases 
remained at a static level with occasional regional outbreaks. In 1995, a revised 
guideline named Modified Action Plan (MAP) gave some lead which renamed as 
National Malaria Eradication Program (NMEP) in 1999. Subsequently this program 
was more disease centric and named as National Vector Borne Disease Control 
Program (NVBDCP) in 2002 [3].
In 2017, 0.84 million malaria cases with 174 related deaths were reported from 
India, while WHO estimated 9.6 million cases with 16,723 malaria-related deaths. 
This may be due to different methods of case estimation. From this state of current 
situation in India, malaria elimination has been envisaged with an aim to achieve it 
by 2030 [1, 4].
2. Malaria elimination initiatives
The global malaria elimination framework was launched in 2007, and a detailed 
Global Technical Strategy (GTS) was released in May 2015 aiming to eliminate 
malaria by 2030. The three recommendations to achieve this goal strongly empha-
size strengthening of smart surveillance; prompt diagnosis and treatment; and 
enhance elimination process. The GTS thus focuses on 35 countries in which to 
eliminate malaria by 2030, and India is one of them [4].
India is one of the countries that have signed the National Framework for 
Malaria Elimination (NFME). The WHO estimated 219 million malaria cases 
with 435,000 related deaths in the world in 2017. This was higher than the previ-
ous years. The WHO Director-General has called an aggressive new approach 
`High Burden to High Impact’ [1]. Of the 11 high malaria burden countries 10 
are from Africa, but India is also under this category. Nearly half of the global 
malaria occurred in Nigeria (25%), the Democratic Republic of the Congo (11%), 
Mozambique (5%) and 4% each by India and Uganda. This means India needs 
a special attention. The NFME has been designed to ease the burden in most 
high burden Indian states especially Odisha, Madhya Pradesh, Chhattisgarh and 
Jharkhand. The major attention should be on strengthening the surveillance which 
is still poor in many states [1, 3].
3. Strengthening of ongoing surveillance
Surveillance is the main pillar in the malaria elimination process. In most situations, 
ongoing surveillance is not consistent with the national guidelines resulting in poor 
estimates of malaria burden. This needs to be converted into smart surveillance. In the 
digital era, all surveillance systems should follow the concept of the  ‘test–treat–track’ 
strategy [5]. Android-based mobile apps can be applied for quick dispensation of 
surveillance data from the field to the local administrator for immediate action. This 
system at district-level management is implemented in many African countries. In this 
way, the time lag between diagnosis and treatment can be minimized [6]. Tracking the 
patient for completion and follow-up of the treatment has wider effects on the local 
cycle of malaria [1]. WHO has developed surveillance and data analysis dashboards 
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using district health information software 2 (DHIS 2) [4]. Such digital-based data 
systems will make the surveillance system smart and efficient.
Strategy to change in surveillance is also an important step to accelerate the 
malaria elimination process. China adopted the ‘1-3-7’ strategy that promoted the 
elimination process with zero indigenous malaria cases in 2017. This strategy envi-
sions the strategic action from diagnosis to treatment within 3 days and public health 
responses to vector management within day 7 of the case detection. This also makes 
an easy platform for establishment of personal communication in the community 
[7]. Indonesia also adopted the ‘1-2-5’ strategy for surveillance and response protocol 
in malaria elimination; on day 1 case management and notification; on day 2 case 
classification and foci investigation; and by day 5 foci response and elimination [8].
In southwestern coastal Mangaluru city, Karnataka state, India, malaria has 
been endemic over two decades. The local authority has implemented indigenously 
developed digital handheld tablets (TABs) for smart surveillance. These TABs have 
been allotted to each health worker after proper training. Now no manual data 
collection is used in the city. The link of the software was also provided to the local 
hospitals and diagnostic labs. The data can be accessed to the local administrators 
for taking action on the feedback received. Here the ‘1-3-7-14’ strategy has been 
adopted where positive case is registered with start of treatment on day 1; comple-
tion of treatment by day 3; on day 7 vector control activities with follow-up smear 
check, and on day 14 follow-up smear check and completion of radical treatment 
for P. vivax cases with primaquine. In this way, the initial response of the anti-
malarial drugs can be assessed. The best part of this system is that all the data can 
be retrieved, and the program can be monitored at all levels, assessing the opening 
and closing of each case. This system creates a great scope of community awareness 
through person-to-person communication [9]. In the dashboard of this system, 
algorithms of specific data can be incorporated for possible prediction of malaria 
outbreaks. Thus, the concept of ‘predict–perform–protect’ can be established using 
artificial intelligence (AI) and machine learning.
A recent study in Bangladesh has found that the movement of people can be 
tracked from the mobile phone network which can help prediction of outbreaks 
of diseases such as malaria. This enables the health authorities to take preventive 
measures in time [10].
4. Quick, efficient and point-of-care diagnosis
Malaria microscopy is still the best method and gold standard for malaria 
diagnosis. A microscopist normally examines 60 blood smears per day. This 
includes staining and data maintaining. Now expert microscopist can detect 20 to 
50 parasites/μl blood that means a 0.001 to 0.005% level of parasitemia. This is not 
the cases with regular microscopists where the sensitivity is low. Routine in-house 
training on the line of continued medical education program can improve the 
efficiency of the microscopists [11].
Recent deployment of Rapid Detection Tests (RDTs) have changed the malaria 
diagnosis at large, but it has failed to detect when the level is <100 parasites/
μl blood. This has become a nagging problem in detecting very low numbers of 
infected red blood cells and sub-microscopic parasites especially gametocytes in 
P. falciparum cases. This necessitated an alternate system of diagnosis. An indig-
enously developed handheld real-time micro-PCR based PDA (personal digital 
assistant) device that can detect parasites as low as 1.3/μl blood has been used 
successfully. This is a point-of-care device that performs tests onsite within 40 min-
utes. About 80 cases can be performed per day. The result of the cases can be shared 
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through an internet system. Thus, case management becomes more efficient and 
effective [12]. Recently, a genome mining based identical multi-repeat sequences 
(IMRS) qPCR assay has been developed for diagnosis of malaria infection. This 
diagnostic method can detect very low level of parasitemia that cannot be detected 
by the routine 18S rRNA-based diagnostic system [13].
5. Tackling sub-microscopic and asymptomatic cases
In recent years, asymptomatic and sub-microscopic cases are reported from 
many endemic countries. In fact, these two aspects are non-synonymous. Sub-
microscopic malaria cases present very low levels of parasitemia which generally 
missed in the routine microscopic examinations. Such cases may be symptomatic, 
and in most situations, these are asymptomatic cases. It has also been observed 
that in most high endemic areas asymptomatic cases with detectable levels of 
parasites do not show symptoms. This is because of a high immune status of the 
individual patients. It is suggested that such cases may be monitored under hospital 
supervision and clinical algorithms can be drawn to know more specific symptoms. 
Possibly such patients may show some kind of symptoms and may be on alternate 
days which are indicative of chronic malaria cases. Differential diagnosis of such 
cases becomes very difficult since they normally do not show any routine symp-
toms. However, experience clinicians can diagnose and successfully treat them with 
scheduled anti-malarials.
On the other hand, asymptomatic cases do not show presentable routine symp-
toms. Once proper diagnosis is confirmed treatment becomes very easy. In our 
experience, patients having malaria-like symptoms who could not be diagnosed 
with routine tests even with RDTs, had been treated for other diseases, mostly 
with antibiotics, but also with anti-tubercular therapy (ATT) for a long time even 
months. It has been observed that most antibiotics with quinoline molecules and 
ATT with rifampicin have anti-malarial properties. But these therapies cannot 
completely eliminate malarial parasites rather reduces the cure rate [14]. Such cases 
show sub-microscopic level of parasites. Normally these parasites do not show 
normal morphological features under microscopy. Only expert microscopists can 
identify such drug-affected parasites. In such cases, it may deem necessary first 
to stop all medicines and wait for the fever or fever-like symptoms to appear, then 
treat them with effective anti-malarials after expert microscopy. All these exercises 
should be done under medical supervision. The post response and relief from agony 
of such patients are remarkable.
Generally an important question is raised by most public health experts whether 
asymptomatic cases may cause potential risk of source of malaria transmission in 
endemic areas. In most endemic areas with high P. falciparum cases, residual load of 
gametocytes remain active in the blood circulation for a considerable period even 
after successful treatment, either with artemisinin-based combination therapy 
(ACT) or radical treatment with primaquine [1]. This can be solved with a simple 
ex vivo tests for detecting the presence of exflagellation. If this happens, it will 
indicate the potency of the gametocytes. This can be further extended to artificial 
membrane or direct feeding on patients (after obtaining human ethical approval) to 
Anopheles stephensi which will be kept at temperature of 28°C and 70–75% relative 
humidity (RH) in a controlled chamber for 7–8 days. Gut dissection on day 7 post-
feeding will confirm the presence of oocysts. The presence of oocysts will indicate 
the potential threat of such gametocytes and their role in active transmission. It 
would be better to know the male and female gametocyte ratio before the experi-
ment is performed. Generally 1 male to 3–5 female gametocytes sex ratio is found 
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in P. falciparum [15]. Post-treatment gametocytemia is commonly detected by a 
quantitative nucleic acid sequence-based amplification (QT-NASBA) method [16]. 
It is better to kill all the fed mosquitoes on day 8 post-feeding so that there will be no 
threat of accidental release of infected mosquitoes for possible malaria infections.
6. Treatment of malaria cases
Chloroquine the cheapest anti-malarial drug is no longer prescribed for the 
treatment of P. falciparum malaria cases. Even monotherapy with artemisinin is 
also not recommended. Currently different ACTs are prescribed for treatment 
of P. falciparum malaria including some P. vivax cases. The partner drugs are 
sulfadoxine-pyrimethamine, piperaquine, lumefantrine, pyrrolidine, etc. In India, 
chloroquine is still efficacious against P. vivax even in the presence of Pvcrt-0 and 
Pvmdr-1 mutations [17]. On the other hand, the presence of kelch 13 (k13) muta-
tions in P. falciparum is linked to artemisinin resistance. Recent report from eastern 
India indicated the presence of two mutations G625R and R539T in 5/72 P. falci-
parum cases treated with artemisinin that linked to its presence of resistance [18]. In 
Africa, where P. falciparum is predominant there is no sign of artemisinin resistance 
even with more than 200 non-synonymous k13 mutations recorded. A recent report 
suggested that artemisinin resistance in a patient can be addressed by changing the 
partner drugs which is responding to the local parasites [19]. Such combination 
should be selected for P. falciparum treatment. Several studies indicated the absence 
of S769 N mutation in PfATPase6 gene responsible for artemisinin resistance [20]. 
Possibly this marker would be the better one for monitoring of artemisinin resis-
tance in most malaria-endemic settings.
6.1 Primaquine and tefenoquine for radical treatment
Primaquine – an 8-aminoquinoline is used for radical cure. In case of P. vivax 
15 mg per day for 14 days and for P. falciparum a single dose of 45 mg is admin-
istered for eliminating hypnozoites for the former and gametocytes for the later, 
respectively. Recently tefenoquine, another 8-aminoquioline, has been recom-
mended. But both of these drugs may cause possible hemolysis in G6PD-deficient 
patients [21]. Attempts are being made to find newer molecules to address this issue. 
In this regard, Medicines for Malaria Venture (MMV) is playing a primary role [22].
7. Change in vector control strategy
There are 465 Anopheles mosquitoes in the world, of which many members 
have sibling species complexes. Approximately 70 of them are capable for human 
malaria transmission [23]. Application of public health insecticides is the main 
strategy for vector control. DDT is the main insecticide and is partially responsible 
for most malaria elimination in Europe and Americas along with general improve-
ment of living standards, and an effective detection and treatment program. Other 
countries missed out this opportunity to achieve this feat. Prolongation of its use 
lead to the development of resistance in the mid-1970s and also recorded the highest 
number of malaria cases. Other insecticides namely malathion (organophospho-
rous) and subsequently synthetic pyrethroids (deltamethrin, alphacypermethrin, 
lambdacyhalothrin, cyfluthrin, etc.) are used in the program. In some endemic 
areas, triple resistance has been recorded against the main rural vector An. culicifa-
cies. Currently long lasting insecticidal nets (LLINs) impregnated with synthetic 
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pyrethroids are widely used in the program. In general, behavioral changes of 
vector mosquitoes are a common phenomenon due to continuous use of IRS insec-
ticides. This leads to outdoor resting and feeding behavior which are responsible for 
outdoor transmission. Some species change their biting time also, and thus becomes 
difficult in managing vector control operations [24].
7.1 Outdoor and residual transmission
Generally outdoor and residual transmissions are considered as the same phe-
nomenon. But these are separate issues and would be dealt separately. Outdoor 
transmission occurs when local community engages on outdoor duties due to profes-
sional compulsion. This is most prevalent in forest fringe areas. For example, An. 
dirus s.l. is the most dominant species in Southeast Asia region. Here LLINs have very 
limited role. Many methods have been suggested, but none have been used for any 
practical purposes. Several traps have been developed in recent years; some are light-
based, some CO2- based, some octanol, commercial attractants based, and some 
with combination of all. Many experts recommend covering the whole body with 
proper clothing especially for security personnel, use of mosquito repellents and 
chemoprevention [1]. Recently Center for Disease control and Prevention (CDC) 
has approved the lemon eucalyptus oil for general use as mosquito repellent [25].
The most disturbing fact is that in most village settings human and cattle have 
mixed dwellings. This encourages the zoophagic mosquitoes to move from the 
bovine host to the humans. Here, a community-level action is needed. Experts rec-
ommend that all cattle dwellings should be located on the periphery of the village 
so there would be a spatial barrier between the foraging mosquitoes and humans. In 
this way, a strong zooprophylaxis would be established and direct human biting can 
be avoided [26].
7.2 Removing shrubs around houses
Outdoor transmission can be effectively contained when flowering shrubs 
around houses are removed. A study in Mali supports such concepts. The selected 
villages where flowering branches of invasive shrub Prosopis juliflora were removed 
experienced a 69.4% drop in Anopheles population density and a shifting of species 
composition [27].
7.3 Attractive toxic sugar bait (ATSB)
Like removing shrubs, ATSB is an alternate strategy to eliminate mosquitoes. 
Sugar bait of 10% sucrose mixed with 0.01% ivermectin soaked in sponge bait 
knocked down over 95% of An. arabiensis population [28]. But it requires commu-
nity engagement for proper implementation [29].
Studies should be carried out to define the bionomics of local vectors. This will 
provide valuable information for planning proper vector control strategies. This 
should be an ongoing program. In the malaria elimination program, routine moni-
toring of vectors will allow appropriate decisions for effective control. Residual 
transmission is a resultant of presence of sub-microscopic level of malarial parasites 
in the community. This happens when intensive control measures overlook the 
residual presence of parasites. Such a situation happens when a type of compla-
cency prevails and the surveillance system becomes fatigued. Many local-level focal 
outbreaks happen, and the public health response activities for vector control fail to 
decimate such foci [30]. It is, thus important to have a strict surveillance system in 
place to avoid such residual transmission and outbreaks.
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7.4 Gene editing
The recent advances in genetic engineering technology of CRISPR/Cas9 
(Clustered Regularly Interspaced Short Palindromic Repeats/Cas9), a system 
targets specific stretches of DNA and edit genomes at specific locations. This tool 
of gene editing/drive technology can revolutionize malaria elimination efforts by 
identifying and targeting the local vectors. The aim should be to create transgenic 
mosquitoes that will not be able to carry the malaria parasites. Some success to cre-
ate transgenic species of the main malaria vector of African countries, An. Gambiae, 
has been achieved [31]. Gene-driven mosquitoes do not follow the Mendelian law of 
inheritance. This technology can be effectively applied to eliminate the invasive and 
endemic species to maintain the conservation of biodiversity [1].
7.5 Fungal application for vector control
Entomopathogenic transgenic fungus Metarhizium pingshaense expressing the 
spider neurotoxin hybrid (met-hybrid) killed 99% of the mosquito population in 
a controlled trial in Burkina Faso. The study was conducted in a trial village of 600 
square meters area or `mosquito sphere’. The test mosquitoes were killed within 
45 days. The researchers hope to find out a new tool to eliminate malaria when 
insecticide resistance is a major problem [32]. Before this field trial, extensive 
laboratory experiments were carried out on the two important malaria species An. 
coluzzii and An. gambiae s.l [33].
7.6 Bioenvironmental control of disease vectors
This is a holistic approach of vector control practiced in the beginning of the 
20th century. The main aim of this approach is source reduction of larval breeding 
habitats. In other words, larval source management is the key strategy that mitigates 
challenges of larval control. Minor engineering, filling up of pools and puddles near 
human habitats, and biological control are some methods of this strategy. Since the 
mid-1980s the ICMR- National Institute of Malaria Research, New Delhi, India has 
made pioneering work on this front with great successes. In this strategy, health 
education and community engagement is an integral part [34].
7.7 Paratransgenesis
Paratransgenesis is a process by which the genetically modified symbionts from 
a target insect express molecules within the vector that show refraction to patho-
gens they transmit. This is a novel approach, now used for the control of malaria, 
trypanosomiasis and dengue. Recently, for the first time, we found Veillonella sp. 
in the gut of An. stephensi which may play an important role in paratransgenesis. A 
diverse microbial community was recorded in the salivary glands in An. culicifacies—
the main malaria vector in rural India [35]. However, this strategy has to go a long 
way for the involvement of gene modification technology [36].
7.8 Jhum cultivation
Jhum or jhoom cultivation or slash and burn cultivation is a common practice 
of cultivation among tribal populations of northeast India and also in some hilly 
districts of Bangladesh. This practice of cultivation is linked with malaria transmis-
sion [37]. Besides using LLINs, it is important to find the main breeding habitats 
of vector species mainly An. dirus s.l. during the dry season. Control of such vector 
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species can be obtained with the application of larvivorous fish mainly in wells 
which act as the ecological niche [1]. Further research may find a new way of 
intervention strategies.
7.9 Intervention with endectocide
Use of endectocide namely ivermectin in mass drug administration program is a 
potential intervention strategy to reduce residual transmission of malaria. This drug 
is used in elimination of human lymphatic filariasis and onchocerciasis programs. 
This old drug was developed from a natural substance by Satoshi Omura from 
Kitasato Institute, Japan and was further developed by William Campbell from 
Merck Lab originally for use in veterinary health program. But its use in onchocer-
ciasis program was recognized for Nobel Prize for Physiology or Medicine in 2015. 
This is used as a potential tool in vector control program when anti-mosquito activi-
ties were recognized. Twenty-three projects under Malaria Elimination Science 
Alliance (MESA) are underway and their results will be available by 2020 that will 
be able to take a decision on the future use of endectocides in malaria control opera-
tions [38]. Besides the mentioned diseases, recent publication has given an overview 
on the use of ivermectin for various neglected tropical diseases (NTDs) that include 
ascariasis, trichuriasis, strongyloidiasis, loiasis (human Loa loa) and mansonel-
liasis [39]. However, adverse effects of ivermectin on local environment have been 
reported. Certain effects on dung beetles Caccobius jessoensis, Copris ochus and Co. 
acutidens have been reported in Japan [40].
7.10 Improved method of mosquito culture
It is important to grow fit and healthy mosquitoes under laboratory conditions 
for anyone working on them. Various methods of culturing of several species of 
mosquitoes are available. Most of malaria research is linked with several species 
Anopheles mosquitoes. Of them An. stephensi is widely used for its easy adaptation 
under laboratory conditions. Routine procedures were followed to colonize this 
species [41–43]. But some modifications in the routine methods gave a significant 
result in mass rearing of An. stephensi [44]:
i. Larval and adult rooms were maintained separately.
ii. For larval room RH was maintained at 45–50%, while temperature at 28°C.
iii. The adult room was maintained 12 hour dark and light periods; temperature 
at 28°C, and RH at 70–75%. Strict monitoring of temperature and humidity 
was maintained.
iv. The eggs laid by adult females in containers were bleached with freshly 
prepared 1% sodium hypochlorite solution for 1 minute under controlled 
pressure in a vacuum pump. For all purposes reverse osmosis (RO) water was 
used in the laboratory and pH of the water maintained around 7.00. About 
250 bleached eggs were placed in especially designed white polypropylene 
trays (Polylab®, India, 375 × 300 × 75 mm3) within a triangle made from 
disposable small straight straw pipes.
v. First instar larvae were emerged within 24 hours after bleaching. No food was 
given in the next 24 hours of hatching. Brewer’s yeast powder dissolved in RO 
water was added in the tray water (300 ml) for the next 2 days.
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vi. Subsequently a special larval food (Brewer’s yeast and dog food at 70:30 ratio) 
were given daily for a specific amount depending on the stage of the larvae. 
Special scoop measuring 5–10 gm larval food in each tray depending on the 
larval age was provided. Pedigree brand dog food (chicken and vegetable 
mixed) were powered in a small grinder and mixed with Brewer’s yeast. This 
formulation was different from earlier report. Pupae were visible from day 8 
onwards.
vii. All pupae were harvested that developed up to day 12, and rest larvae were 
discarded following proper procedure. The pupae were bleached with freshly 
prepared 1% sodium hypochlorite solution for 1 minute, and placed in 
mosquito cages for emergence in to adults.
viii. The adult mosquitoes were provided with a mixture of 8% sucrose, 2%  
glucose mixed with 3% multivitamin kid syrup (Polybion® L, Merck 
Limited, India).
ix. Strict operational procedures were followed for maintaining sterile condi-
tions for all steps.
x. This modified protocol would be very useful for mosquito research.
8. Discussion
The very decision to go for malaria elimination with the existing tools and inter-
vention strategies was very challenging. Many initiatives have been undertaken. 
The President’s Malaria Initiative (PMI) in 2005 to Malaria Elimination Research 
Alliance—India (MERA—India) in 2019 are all to accelerate the process of malaria 
elimination in all the high burden areas especially in Africa, Mekong Delta region 
and India, respectively [1]. A special initiative by the WHO in 2016, 21 endemic 
countries was identified for malaria elimination by 2020 i.e. E-2020 initiative [1]. 
In this direction zero malaria cases were reported from China and El Salvador in 
2017. In 2018, Paraguay was certified as malaria free by the WHO. In 2019, Algeria 
achieved this goal. Three countries—the Islamic Republic of Iran, Malaysia and 
Timor-Leste—achieved zero malaria cases in 2018. In 2016, Sri Lanka achieved 
zero malaria certification, but in 2018 local transmission was reported from a case 
imported from India. But the local authorities immediately took action. Such quick 
public health response is required to maintain no transmission threat [45].
Vector control operations mainly rely on insecticide sprays. In most situations 
the spray operations are carried out by the local contract workers not properly 
trained; the spray equipments also not maintained properly; pressure not main-
tained while spraying; patchy and low coverage spraying; late supply of materials 
that force to defer the spray schedule; lack of supervision, low quality materials, 
improper storing warehouse, etc. All these confounding factors are responsible for 
continuation of transmission. Vector behavior also changes for prolonged insecti-
cidal mode of operations [24].
Assessment of two important parameters—human blood index (HBI) and 
entomological inoculation rate (EIR) of important local vectors enable workers 
to develop an effective vector management. The global map of HBI of important 
malaria vectors revealed the highest index exists in African countries [26]. This 
indicates low ratio between human and animal populations forcing the vector mos-
quitoes feeding on human host. Emphasis on encouraging the local community to 
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grow animals should be given priority which will change the transmission potential 
if the local vectors are primarily zoophagic [1].
Bioenvironmental control of vector populations is a part of the integrated vector 
management (IVM) concept. In this process control of other vectors of related dis-
eases can also be achieved. Swachh Bharat Abhiyan/Mission (Clean India Movement) 
can be linked in such activity to gain better results. Larval Source Management 
using larvivorous fish is one of the intervention tools under IVM. This strategy is 
very effective when implemented at grass root levels with proper supervision and 
monitoring. Little or no serious emphasis has been given to this strategy. In many 
situations, it is overlooked and demeaned compared to other methods, mostly 
insecticides are available in hand. In fact, it works as a `social vaccine’. Globally, 
around 300 fish species have been identified as larvivorous nature. Two Poeciliid 
fish Poecilia reticulata and Gambusia affinis are widely used. The former is best for 
wells and other confined water bodies, while the later one is best for ponds and 
lakes [1]. There are many reports on adverse effects of the non-native fish on the 
local fish, but recent meta-analysis does not support this theory [46].
A new anti-larval product Aquatain AMF™ is available for anti-larval operation. 
It is a silicon-bases liquid (polydimethylsilicone—PDMS) formulation that forms a 
very thin film on standing water surface causing physical cover over its entire exten-
sion. The mosquito larvae are killed due to physical and mechanical action. There 
does not seem to develop insect resistance to this technique [47].
Community engagement through health education and empowering local 
policymakers help in taking appropriate decisions in vector control. Engaging some 
local school children as volunteers will laterally support such program [48]. In 
India, every year June is observed as anti-malaria month. Several activities high-
lighting the program on malaria are displayed. Local administration also actively 
takes part and makes some decisive actions.
Two vaccine candidates RTS, S/AS01 (TRADE NAME Mosquirix) and PfSPZ 
are under trial even though their protection level is moderately low. The former is 
undergoing phase 3 trial in children in three African countries. Possibly this will help 
reducing child mortality which is a major concern in most of African countries [1].
India contributes most of P. vivax malaria cases outside the high burden districts 
where P. falciparum is most dominant. Recent studies also indicate the presence of P. 
ovale curtisi and P. ovale wallikeri. P. malariae is also co-existent in the high burden 
tribal districts. All these are possible due to application of molecular diagnostic 
techniques [49]. Expert recommended genome mining studies which will unravel 
some underlying issues of malaria epidemiology [13]. Moreover, molecular DNA 
bar coding of parasites will also help in identifying their actual geographic origin 
[50]. This will surely assist in managing the drug resistance problem.
The recent identification of P. knowlesi as a human malaria with a zoonotic 
source prevalent in Malaysia and Southeast Asian countries may be very important 
[51]. Another disturbing factor is recent discovery of P. falciparum infection in two 
common Indian non-human primates Macaca mulatta and M. radiata [52]. This 
matter should be taken seriously when malaria elimination is underway. A distinct 
barrier between human and animal is essential to the ongoing elimination efforts.
9. Conclusion
There is a great movement and opportunity for malaria elimination globally. 
Many countries have already achieved this goal. The most success part of this 
movement is reporting zero malaria cases in China in 2017 and 2018, and preparing 
for malaria elimination certification in 2020. China made elaborate arrangements 
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with full financial, administrative and operational commitment. This indicates that 
malaria elimination is possible with the existing tools and strategies. In the present 
situation dependence of insecticide should be minimized and promote other alter-
nate strategies to avert the issue of insecticide resistance. India is making all efforts 
for a successful mission. Reduction of malaria cases and related deaths in 2017 is an 
indication. This was mainly the efforts made in eight most high burden districts in 
Odisha with the implementation of a program called Durgama Anchalare Malaria 
Nirakaran (DAMaN malaria elimination in inaccessible areas). Such initiatives 
should be implemented in other areas also [1].
In the elimination phase, there is a need to strengthen the existing public health 
system. The local health system should be quick and responsive to any malaria-
related fevers. Routine in-house training, workshops should be conducted to 
maintain the malaria elimination momentum. A recent 5 days WHO workshop for 
South-East Asia Region (SEAR) recommended the global vector control response 
(GVCR). Entomologists from 11 countries participated in this workshop. Detailed 
reviews were exercised to find out the ongoing program implementation in each 
country. Such state-level workshops would help in malaria elimination and also 
other vector borne diseases [53].
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